9 METERS BIOPHARMA, INC. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2015 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
9 Meters Biopharma, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2015 to Q1 2023.
  • 9 Meters Biopharma, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2023 was -$226M, a 25.7% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 -$226M -$46.3M -25.7% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$213M -$43.8M -25.9% Dec 31, 2022 10-Q 2023-05-15
Q3 2022 -$201M -$41.4M -26% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$191M -$45.6M -31.3% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 -$180M -$42.7M -31.1% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 -$169M -$36.8M -27.9% Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$159M -$32.2M -25.3% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 -$146M -$27M -22.7% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 -$137M -$63.3M -85.4% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 -$132M -$61.5M -87.1% Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$127M -$65.4M -106% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 -$119M -$66.3M -126% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 -$74.2M -$26.2M -54.7% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 -$70.6M -$27M -62.2% Dec 31, 2019 10-K 2021-03-22
Q3 2019 -$61.7M -$22.4M -56.9% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 -$52.4M -$13.9M -36.1% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 -$48M -$13.6M -39.7% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 -$43.5M -$24.2M -125% Dec 31, 2018 10-K 2020-03-20
Q3 2018 -$39.3M -$1.83M -4.88% Sep 30, 2018 10-K 2019-03-18
Q2 2018 -$38.5M -$2.56M -7.12% Jun 30, 2018 10-K 2019-03-18
Q1 2018 -$34.3M +$15.6K +0.05% Mar 31, 2018 10-K 2019-03-18
Q4 2017 -$19.4M +$12.7M +39.7% Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$37.5M -$6.65M -21.6% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 -$36M -$6.97M -24% Jun 30, 2017 10-Q 2017-08-21
Q1 2017 -$34.3M Mar 31, 2017 10-Q 2017-05-19
Q4 2016 -$32.1M -$6.21M -24% Dec 31, 2016 10-K 2018-03-14
Q3 2016 -$30.8M Sep 30, 2016 10-Q 2016-11-16
Q2 2016 -$29M Jun 30, 2016 10-Q 2016-08-15
Q4 2015 -$25.9M Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.